Rheumatoid arthritis following PEG-interferon-alfa-2a plus ribavirin treatment for chronic hepatitis C: a case report and review of the literature

BACKGROUND: The combination of Pegylated Interferon-alpha (PEG-IFN-α) and ribavirin is the current standard of care for the treatment of HCV infection. Unfortunately, IFN-α may lead to the induction or exacerbation of autoimmune diseases, such as psoriasis, thyroiditis, systemic lupus erythematosus...

Descripción completa

Detalles Bibliográficos
Autores principales: Cacopardo, Bruno, Benanti, Francesco, Pinzone, Marilia Rita, Nunnari, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815306/
https://www.ncbi.nlm.nih.gov/pubmed/24171974
http://dx.doi.org/10.1186/1756-0500-6-437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815306/
https://www.ncbi.nlm.nih.gov/pubmed/24171974
http://dx.doi.org/10.1186/1756-0500-6-437

Ejemplares similares